Sen-Jam Pharmaceutical Opens Enrollment For Patients In Their COVID Therapy Phase 2 Clinical Trial In Nepal And Engages With Strategic Investor For Worldwide Distribution'

Press/Media

Period6 May 2022

Media coverage

1

Media coverage

  • TitleSen-Jam Pharmaceutical Opens Enrollment For Patients In Their COVID Therapy Phase 2 Clinical Trial In Nepal And Engages With Strategic Investor For Worldwide Distribution'
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date6/05/22
    PersonsAlex Limkaken